Ove informacije su namenjene isključivo u edukativne svrhe. Ne predstavljaju medicinski savet. Uvek se konsultujte sa kvalifikovanim zdravstvenim stručnjakom.
Opis, Doziranje, Neželjena dejstva, Kontraindikacije. Data from EMA, URPL, openFDA and other regulatory sources.
| Ciprofloxacin | Levofloxacin | |
|---|---|---|
| Aktivne supstance | CIPROFLOXACIN | LEVOFLOXACIN |
| ATC šifra | J01MA01 | J01MA01 |
| Oblik | FOR SUSPENSION | SOLUTION/DROPS |
| Doziranje | 250MG/5ML | 0.5% |
| Način primene | ORAL | OPHTHALMIC |
| Proizvođač | BAYER HEALTHCARE PHARMACEUTICALS INC | RUBICON RESEARCH LTD |
Ciprofloxacin (INN: CIPROFLOXACIN, ATC J01MA01) and Levofloxacin (INN: LEVOFLOXACIN, ATC J01MA01) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Ove informacije su namenjene isključivo u edukativne svrhe. Ne predstavljaju medicinski savet. Uvek se konsultujte sa kvalifikovanim zdravstvenim stručnjakom.